NCT07661654

Brief Summary

The goal of this clinical trial is to learn whether Health Belief Model (HBM)-based educational interventions can improve knowledge and practices related to Retinopathy of Prematurity (ROP) screening among parents of premature infants attending ROP clinics in Karachi, Pakistan. The main questions it aims to answer are:

  • Do HBM-based educational interventions improve parents' knowledge about Retinopathy of Prematurity screening?
  • Do HBM-based educational interventions improve parents' screening-related practices and follow-up for Retinopathy of Prematurity? Researchers will compare different educational approaches, including video-based education, audio-based education, and standard educational material, to see which method is more effective in improving parental understanding and practices regarding ROP screening. Participants will:
  • Complete a questionnaire assessing their knowledge and practices related to Retinopathy of Prematurity screening at baseline
  • Receive one of the following educational approaches: video message plus counselling and pamphlet, audio message plus counselling and pamphlet, or counselling and pamphlet only
  • Attend a follow-up visit approximately 2 weeks after the initial visit
  • Complete a follow-up questionnaire to assess changes in knowledge and practices related to Retinopathy of Prematurity screening

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable

Timeline
8mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jul 2026Apr 2027

First Submitted

Initial submission to the registry

June 11, 2026

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
9 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2027

Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

7 months

First QC Date

June 11, 2026

Last Update Submit

June 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Retinopathy of Prematurity Knowledge Score

    Knowledge regarding Retinopathy of Prematurity (ROP) will be assessed using a structured 10-item ROP Knowledge Questionnaire completed by parents. Items assess knowledge related to ROP risk factors, screening, treatment, and complications. Correct responses receive a score of 1 and incorrect or "I do not know" responses receive a score of 0. Total scores range from 0 to 10, with higher scores indicating better knowledge. Change in total score will be assessed by comparing baseline and follow-up questionnaire scores.

    Baseline to follow-up visit (approximately 2 weeks after initial visit)

Secondary Outcomes (1)

  • Change in HBM Perceptions Regarding ROP Screening

    Baseline to follow-up visit (approximately 2 weeks after initial visit)

Study Arms (3)

Video Message + Counselling + Pamphlet

EXPERIMENTAL

Participants will receive a Health Belief Model-based educational video regarding Retinopathy of Prematurity (ROP), along with counselling by an ophthalmologist and a user-friendly educational pamphlet in English or Urdu.

Behavioral: HBM-Based Video Education

Audio Message + Counselling + Pamphlet

EXPERIMENTAL

Participants will receive a Health Belief Model-based educational audio message regarding Retinopathy of Prematurity (ROP), along with counselling by an ophthalmologist and a user-friendly educational pamphlet in English or Urdu.

Behavioral: HBM-Based Audio Education

Counselling + Pamphlet (Control)

ACTIVE COMPARATOR

Participants will receive standard educational information through counselling by an ophthalmologist and a user-friendly educational pamphlet regarding Retinopathy of Prematurity (ROP).

Behavioral: Standard Counselling and Pamphlet

Interventions

Participants will receive a Health Belief Model-based educational audio message regarding Retinopathy of Prematurity (ROP), including information on disease development, risk factors, importance of timely screening, treatment options, and follow-up. Counselling by an ophthalmologist and a user-friendly pamphlet in English or Urdu will also be provided.

Audio Message + Counselling + Pamphlet

Participants will receive standard educational information through counselling by an ophthalmologist and a user-friendly pamphlet regarding Retinopathy of Prematurity (ROP). Educational materials will be provided in English or Urdu.

Counselling + Pamphlet (Control)

Participants will receive a Health Belief Model-based educational video regarding Retinopathy of Prematurity (ROP), including information on disease development, risk factors, importance of timely screening, treatment options, and follow-up. Counselling by an ophthalmologist and a user-friendly pamphlet in English or Urdu will also be provided.

Video Message + Counselling + Pamphlet

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Mother or father of a premature infant attending Retinopathy of Prematurity (ROP) clinic
  • Parent aged 18 years or older
  • Parent of a premature infant who was admitted to the Neonatal Intensive Care Unit (NICU)
  • Able to understand English or Urdu
  • Willing and able to provide written informed consent

You may not qualify if:

  • Parents with disability or cognitive impairment affecting participation
  • Uncooperative participants
  • Parents unwilling or unable to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Retinopathy of Prematurity

Condition Hierarchy (Ancestors)

Retinal DiseasesEye DiseasesInfant, Premature, DiseasesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Khadijah Abid

    Aga Khan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fariha Ali

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors responsible for evaluating study outcomes will remain blinded to participant group assignments. A separate assessment team not involved in intervention delivery and without access to the randomization list will conduct outcome assessments. Investigators delivering educational interventions will not be blinded due to the nature of the intervention.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants will be randomized into one of three parallel groups to receive Health Belief Model-based educational interventions related to Retinopathy of Prematurity (ROP). Group 1 will receive a video message, counselling, and a user-friendly pamphlet; Group 2 will receive an audio message, counselling, and a user-friendly pamphlet; and Group 3 (control) will receive counselling and a user-friendly pamphlet only. Participants will remain in their assigned group throughout the study period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sr. Instructor (Research)

Study Record Dates

First Submitted

June 11, 2026

First Posted

June 22, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

April 1, 2027

Last Updated

June 22, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to participant confidentiality considerations and institutional data protection policies. The study involves questionnaire-based data collected from parents of premature infants, and no formal data-sharing agreement or repository is planned as part of the approved study protocol.